Jonathan F. Goodwin
- Molecular Biology
- Oncology top 10%
- Pulmonary and Respiratory Medicine top 10%
- Cancer Research
- Genetics
- Co-authors
- Karen E. KnudsenMatthew J. SchiewerJeffry L. DeanRandy S. SchrecengostRenée de LeeuwFelix Y. FengSumin HanAdam P. Dicker
- Topics
- Prostate Cancer Treatment and Research (4 papers)PARP inhibition in cancer therapy (3 papers)Cancer-related Molecular Pathways (2 papers)
- Partner nations
- United StatesAustraliaNorway
In The Last Decade
Jonathan F. Goodwin
7 papers receiving 663 citations
Peers
Comparison fields: 5 of 56
- Molecular Biology 422
- Oncology 307
- Pulmonary and Respiratory Medicine 299
- Cancer Research 133
- Genetics 54
Countries citing papers authored by Jonathan F. Goodwin
This map shows the geographic impact of Jonathan F. Goodwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan F. Goodwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan F. Goodwin more than expected).
Fields of papers citing papers by Jonathan F. Goodwin
This network shows the impact of papers produced by Jonathan F. Goodwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan F. Goodwin. The network helps show where Jonathan F. Goodwin may publish in the future.
Co-authorship network of co-authors of Jonathan F. Goodwin
This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan F. Goodwin. A scholar is included among the top collaborators of Jonathan F. Goodwin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan F. Goodwin. Jonathan F. Goodwin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 29 | |
| 3 | 1 | |
| 4 | 188 | |
| 5 | 99 | |
| 6 | 265 | |
| 7 | 81 |
About Jonathan F. Goodwin
Jonathan F. Goodwin is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cell Biology, having authored 7 papers that have together received 670 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (4 papers), PARP inhibition in cancer therapy (3 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Oncology (307 citations), Pulmonary and Respiratory Medicine (299 citations) and Cancer Research (133 citations). Jonathan F. Goodwin has collaborated with scholars based in United States, Australia and Norway. Frequent co-authors include Karen E. Knudsen, Matthew J. Schiewer, Jeffry L. Dean, Randy S. Schrecengost, Renée de Leeuw, Felix Y. Feng, Sumin Han, Adam P. Dicker, Teng Ma and Robert B. Den. Their work appears in journals such as Cancer Research, Oncogene and Cancer Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.